Advertisement
Screener

MYRIAD GENETICS, INC. (MYGN) Property, Plant and Equipment

2.8 / 5 stars · 68/120 Roast Me

MYRIAD GENETICS, INC. Property, Plant and Equipment

MYRIAD GENETICS, INC. (MYGN) had Property, Plant and Equipment of $108.90 million as of 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization

us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-07-31

  • 2026-06-30: Property, Plant and Equipment, Net $108.90M.
  • 2026-03-31: Property, Plant and Equipment, Net $111.50M.
  • 2025-12-31: Property, Plant and Equipment, Net $114.00M.
  • 2025-09-30: Property, Plant and Equipment, Net $111.40M.
Period endProperty, Plant and Equipment, NetProperty, Plant and Equipment, Net as first filed
2026-06-30$108.90M
10-Q · filed 2026-07-31
2026-03-31$111.50M
10-Q · filed 2026-05-06
2025-12-31$114.00M
10-Q · filed 2026-07-31
2025-09-30$111.40M
10-Q · filed 2025-11-04
2025-06-30$113.00M
10-Q · filed 2025-08-06
2025-03-31$114.00M
10-Q · filed 2025-05-07
2024-12-31$117.40M
10-K · filed 2026-02-24
2024-09-30$115.40M
10-Q · filed 2024-11-08
2024-06-30$116.30M
10-Q · filed 2024-08-07
2024-03-31$118.50M
10-Q · filed 2024-05-08
2023-12-31$119.00M
10-K · filed 2025-02-28
2023-09-30$120.70M
10-Q · filed 2023-11-07
2023-06-30$112.00M
10-Q · filed 2023-08-04
2023-03-31$96.30M
10-Q · filed 2023-05-04
2022-12-31$83.40M
10-K · filed 2024-02-28
2022-09-30$67.50M
10-Q · filed 2022-11-02
2022-06-30$52.80M
10-Q · filed 2022-08-05
2022-03-31$45.70M
10-Q · filed 2022-05-06
2021-12-31$43.50M
10-K · filed 2023-03-01
2021-09-30$43.40M
10-Q · filed 2021-11-04
2021-06-30$43.20M
10-Q · filed 2021-08-04
2021-03-31$45.10M
10-Q · filed 2021-05-05
2020-12-31$40.70M
10-K · filed 2022-02-25
2020-09-30$36.70M
10-Q · filed 2020-11-09
2020-06-30$37.00M
10-KT · filed 2021-03-16
2020-03-31$37.10M
10-Q · filed 2020-05-06
2019-12-31$36.50M
10-Q · filed 2020-02-07
2019-09-30$55.00M
10-Q · filed 2019-11-06
2019-06-30$57.30M
10-KT · filed 2021-03-16
2019-03-31$58.70M
10-Q · filed 2019-05-08
2018-12-31$59.10M
10-Q · filed 2019-02-06
2018-09-30$59.10M
10-Q · filed 2019-02-06
$60.00M
10-Q · filed 2018-11-07
2018-06-30$43.20M
10-K · filed 2019-08-13
2018-03-31$48.20M
10-Q · filed 2018-05-09
2017-12-31$48.40M
10-Q · filed 2018-02-07
2017-09-30$49.80M
10-Q · filed 2017-11-08
2017-06-30$51.10M
10-K · filed 2018-08-24
2017-03-31$53.00M
10-Q · filed 2017-05-03
2016-12-31$54.70M
10-Q · filed 2017-02-08
2016-09-30$56.80M
10-Q · filed 2016-11-02
2016-06-30$58.30M
10-K · filed 2017-08-09
2016-03-31$60.00M
10-Q · filed 2016-05-04
2015-12-31$61.70M
10-Q · filed 2016-02-03
2015-09-30$64.90M
10-Q · filed 2015-11-04
2015-06-30$67.20M
10-K · filed 2016-08-10
2015-03-31$69.10M
10-Q · filed 2015-05-06
2014-12-31$46.46M
10-Q · filed 2015-02-04
2014-09-30$43.42M
10-Q · filed 2014-11-05
2014-06-30$34.60M
10-K · filed 2015-08-12
$34.59M
10-K · filed 2014-08-13
2014-03-31$32.66M
10-Q · filed 2014-05-07
2013-12-31$31.31M
10-Q · filed 2014-02-05
2013-09-30$30.68M
10-Q · filed 2013-11-12
2013-06-30$27.60M
10-K · filed 2014-08-13
2013-03-31$26.88M
10-Q · filed 2013-05-08
2012-12-31$27.29M
10-Q · filed 2013-02-06
2012-09-30$24.76M
10-Q · filed 2012-11-09
2012-06-30$24.23M
10-K · filed 2013-08-14
2012-03-31$24.10M
10-Q · filed 2012-05-02
2011-12-31$24.33M
10-Q · filed 2012-02-01
2011-09-30$23.26M
10-Q · filed 2011-11-02
2011-06-30$23.08M
10-K · filed 2012-08-15
2011-03-31$21.34M
10-Q · filed 2011-05-04
2010-06-30$23.26M
10-K · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92